Akkure

Dublin, Ireland Founded: 2016 • Age: 10 yrs
Blockchain-based platform for genomic data analytics is provided.

About Akkure

Akkure is a Healthcare company based in Dublin (Ireland) founded in 2016 by Amy Hollingworth and Oran Rigby. Blockchain-based platform for genomic data analytics is provided. Akkure has raised $3.37 million across 3 funding rounds from investors including Enterprise Ireland and Digital Transformation Innovation Fund. Akkure offers products and services including AI Cancer Trial Finder and Genomics Platform. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials.

Company details

Akkure was established in 2016 in Dublin, Ireland, within the genomics and blockchain sectors. An online platform is operated for handling genomic data, where user control and management of data are facilitated, including rewards for sharing. Connections are enabled between researchers and organizations for ordering DNA test kits, obtaining sequencing results, and conducting data analysis. Blockchain technology is employed to support the sharing and management of research analytics.

Key Metrics
  • Total Equity Funding
    $3.37M (USD)

    in 3 rounds

  • Latest Funding Round
    $718.06K (USD), Grant

    Nov 2022

  • Investors

Products & Services of Akkure

Akkure offers a comprehensive portfolio of products and services, including AI Cancer Trial Finder and Genomics Platform.

AI Cancer Trial Finder
Trial Matching Platform

Tool for precise patient matching to cancer trials using AI

Genomics Platform
Data Analysis Tool

Platform streamlining clinical trial recruitment for hospitals

Funding Insights of Akkure

Akkure has successfully raised a total of $3.37M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $718.06 thousand completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $3.37M
  • Total Rounds 3
  • Last Round Grant β€” $718,060
  • First Round $1.43M

    (Jan 2021)

  • Investors Count 2

All 3 funding rounds of Akkure with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2022$718,060Grant––
Jun 2021$1.94MSeed–Enterprise Ireland
–
Jan 2021$1.43MSeed––
–
Valuation history

2 investors in total: 2 institutional.

Investors in Akkure

Akkure has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Enterprise Ireland and Digital Transformation Innovation Fund.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Support is provided to Irish manufacturing and service sector businesses.
1998enterprise-ireland.comDublin, Ireland
Premium access

Investor details for Akkure

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Akkure

4 people are tracked at Akkure (3 in leadership, 1 in team).

NameRoleGroup
Amy Hollingworth
Co-FounderLeadership
Oran Rigby
Co-FounderLeadership
Fergal Rigby
Chief Operating OfficerLeadership
Keith O'Sullivan
Unknown RoleTeam
Premium access

Complete people profiles for Akkure

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Akkure

3 dated milestones of Akkure across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded Akkure is founded.
  2. Funding First funding round of $1.4M.
  3. Funding Latest funding round, Grant, of $718K.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Akkure

Premium access

Complete news archive for Akkure

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akkure

Akkure was founded in 2016 and raised its 1st funding round 5 years after it was founded.

Akkure is headquartered in Dublin, Ireland.

Akkure is a funded company, having raised a total of $3.37M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.43M, raised on Jan 2021.

Akkure was established in 2016 in Dublin, Ireland, within the genomics and blockchain sectors. An online platform is operated for handling genomic data, where user control and management of data are facilitated, including rewards for sharing. Connections are enabled between researchers and organizations for ordering DNA test kits, obtaining sequencing results, and conducting data analysis. Blockchain technology is employed to support the sharing and management of research analytics.

Akkure offers AI Cancer Trial Finder and Genomics Platform.

Akkure has 2 investors. Key investors include Enterprise Ireland, and Digital Transformation Innovation Fund.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available